EQRx Inc Valuation
| EQRXWDelisted Stock | USD 0.19 0.01 5.00% |
EQRx seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of EQRx Inc from evaluating the firm fundamentals such as EBITDA of (517.58 M), net income of (169.09 M), and Cash Per Share of 10.51 X as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that EQRx's price fluctuation is very steady at this time. Calculation of the real value of EQRx Inc is based on 3 months time horizon. Increasing EQRx's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EQRx stock is determined by what a typical buyer is willing to pay for full or partial control of EQRx Inc. Since EQRx is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EQRx Stock. However, EQRx's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.19 | Real 0.15 | Hype 0.19 |
The intrinsic value of EQRx's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence EQRx's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of EQRx Inc helps investors to forecast how EQRx stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EQRx more accurately as focusing exclusively on EQRx's fundamentals will not take into account other important factors: EQRx Total Value Analysis
EQRx Inc is currently anticipated to have takeover price of 0 with market capitalization of 0, debt of 3.83 M, and cash on hands of 456.47 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EQRx fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 3.83 M | 456.47 M |
EQRx Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of EQRx indicates not a very effective usage of assets in November.EQRx Profitability Analysis
Net Loss for the year was (169.09 M) with profit before overhead, payroll, taxes, and interest of 0.About EQRx Valuation
Our relative valuation model uses a comparative analysis of EQRx. We calculate exposure to EQRx's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EQRx's related companies.EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. EQRx, Inc. was founded in 2020 and is based in Cambridge, Massachusetts. Eqrx Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 216 people.
EQRx Growth Indicators
Investing in growth stocks can be very risky. If the company such as EQRx does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 474.3 M |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Consideration for investing in EQRx Stock
If you are still planning to invest in EQRx Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EQRx's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |